Back
United Therapeutics Corp. Stock Price Chart
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
59
UTHR
United Therapeutics Corp.
Last Price:
$487.13
Seasonality Move:
1.5%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
The current trend is moderately bearish and UTHR is experiencing selling pressure, which indicates risk of future bearish movement.
United Therapeutics Corp. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 496.25 | Sell |
| 20-day SMA: | 500.94 | Sell |
| 50-day SMA: | 479.89 | Buy |
| 200-day SMA: | 369.46 | Buy |
| 8-day EMA: | 497.79 | Sell |
| 20-day EMA: | 496.49 | Sell |
| 50-day EMA: | 478 | Buy |
| 200-day EMA: | 401.34 | Buy |
United Therapeutics Corp. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.59 | Buy |
| Relative Strength Index (14 RSI): | 48.63 | Sell |
| Chaikin Money Flow: | -167279 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (485.6 - 508.72) | Sell |
| Bollinger Bands (100): | (384.66 - 494.94) | Buy |
United Therapeutics Corp. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for United Therapeutics Corp. Stock
Is United Therapeutics Corp. Stock a Buy?
-
United Therapeutics Corp. share price is 490.83 while UTHR 8-day simple moving average is 496.25, which is a Sell signal.
-
The stock price of UTHR is 490.83 while United Therapeutics Corp. 20-day SMA is 500.94, which makes it a Sell.
-
United Therapeutics Corp. 50-day simple moving average is 479.89 while UTHR share price is 490.83, making it a Buy technically.
-
UTHR stock price is 490.83 and United Therapeutics Corp. 200-day simple moving average is 369.46, creating a Buy signal.
UTHR Technical Analysis vs Fundamental Analysis
Buy
59
United Therapeutics Corp. (UTHR)
is a Buy
Is United Therapeutics Corp. a Buy or a Sell?
-
United Therapeutics Corp. stock is rated a BuyThe current United Therapeutics Corp. [UTHR] share price is $490.83. The Score for UTHR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
United Therapeutics Corp. Stock Info
Market Cap:
21.1B
Price in USD:
490.83
Share Volume:
329.9K
United Therapeutics Corp. 52-Week Range
52-Week High:
519.99
52-Week Low:
266.98
Buy
59
United Therapeutics Corp. (UTHR)
is a Buy
United Therapeutics Corp. Share Price Forecast
-
What is the United Therapeutics Corp. stock price today?The United Therapeutics Corp. stock price is 490.83 USD today.
-
Will UTHR stock go up or go down?United Therapeutics Corp.> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics Corp. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics Corp. is not overvalued.
Is United Therapeutics Corp. Stock a Buy?
-
United Therapeutics Corp. share price is 490.83 while UTHR 8-day exponential moving average is 497.79, which is a Sell signal.
-
The stock price of UTHR is 490.83 while United Therapeutics Corp. 20-day EMA is 496.49, which makes it a Sell.
-
United Therapeutics Corp. 50-day exponential moving average is 478.00 while UTHR share price is 490.83, making it a Buy technically.
-
UTHR stock price is 490.83 and United Therapeutics Corp. 200-day simple moving average is 401.34, creating a Buy signal.
Fundamental Analysis of United Therapeutics Corp.
Is United Therapeutics Corp. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.81 per share, and an increase next year of $1.56 per share.
Technical Analysis of United Therapeutics Corp.
Should I short United Therapeutics Corp. stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is 4.59, suggesting United Therapeutics Corp. is a Buy
-
United Therapeutics Corp. Relative Strength Index (RSI) is 48.63, which suggest United Therapeutics Corp. is oversold
-
The Bollinger Bands (25) for United Therapeutics Corp. is (485.6 - 508.72), which suggest United Therapeutics Corp. is a Buy
-
The Bollinger Bands (100) for United Therapeutics Corp. is (384.66 - 494.94), which suggest United Therapeutics Corp. is a Buy
* United Therapeutics Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.